A Panel of Serum MiRNA Biomarkers for the Diagnosis of Severe to Mild Traumatic Brain Injury in Humans

Overview

Journal Sci Rep

Specialty Science

Date 2016 Jun 25

PMID 27338832

Citations 77

Authors

Manish Bhomia

Nagaraja S Balakathiresan

Kevin K Wang

Linda Papa

Radha K Maheshwari

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (MiRNAs) are small endogenous RNA molecules and have emerged as novel serum diagnostic biomarkers for several diseases due to their stability and detection at minute quantities. In this study, we have identified a serum miRNA signature in human serum samples of mild to severe TBI, which can be used for diagnosis of mild and moderate TBI (MMTBI). Human serum samples of MMTBI, severe TBI (STBI), orthopedic injury and healthy controls were used and miRNA profiling was done using taqman real time PCR. The real time PCR data for the MMTBI, STBI and orthopedic injury was normalized to the control samples which showed upregulation of 39, 37 and 33 miRNAs in MMTBI, STBI and orthopedic injury groups respectively. TBI groups were compared to orthopedic injury group and an up-regulation of 18 and 20 miRNAs in MMTBI and STBI groups was observed. Among these, a signature of 10 miRNAs was found to be present in both MMTBI and STBI groups. These 10 miRNAs were validated in cerebrospinal fluid (CSF) from STBI and four miRNAs were found to be upregulated in CSF. In conclusion, we identified a subset of 10 unique miRNAs which can be used for diagnosis of MMTBI and STBI.

Citing Articles

Identification of novel microRNAs: Biomarkers for pathogenesis of hepatocellular carcinoma in mice model.

Priya S, Kma L Biochem Biophys Rep. 2025; 41:101896.

PMID: 39881957 PMC: 11774814. DOI: 10.1016/j.bbrep.2024.101896.

Brain health in Norwegian female former top-level football players: a protocol for a longitudinal cohort study.

Dahlen S, Bjorneboe J, Sandmo S, Bache-Mathisen L, Filipcik P, Howe E BMJ Open. 2025; 15(1):e092456.

PMID: 39800397 PMC: 11751818. DOI: 10.1136/bmjopen-2024-092456.

Exploring New and Promising Genetic Biomarkers for Evaluating Traumatic Brain Injuries: A Case-Control Study.

Rabou Y, Zayed A, Fahim S, Abdelgwad M, Fiki A, Fayed N Neurochem Res. 2024; 50(1):48.

PMID: 39641810 PMC: 11624226. DOI: 10.1007/s11064-024-04292-9.

Chronic Traumatic Encephalopathy: A Comprehensive Narrative Review of Its Biomarkers.

Majeed A, Naz N, Namal F, Tahir S, Karmani V Cureus. 2024; 16(9):e69510.

PMID: 39421082 PMC: 11485022. DOI: 10.7759/cureus.69510.

A Pilot Study of Saliva MicroRNA Signatures in Children with Moderate-to-Severe Traumatic Brain Injury.

Ciancaglini R, Botash A, Armijo-Garcia V, Hymel K, Thomas N, Hicks S J Clin Med. 2024; 13(17).

PMID: 39274278 PMC: 11396305. DOI: 10.3390/jcm13175065.

References

Papa L, Robertson C, Wang K, Brophy G, Hannay H, Heaton S . Biomarkers improve clinical outcome predictors of mortality following non-penetrating severe traumatic brain injury. Neurocrit Care. 2014; 22(1):52-64. DOI: 10.1007/s12028-014-0028-2. View

Redell J, Moore A, Ward 3rd N, Hergenroeder G, Dash P . Human traumatic brain injury alters plasma microRNA levels. J Neurotrauma. 2010; 27(12):2147-56. PMC: 6468948. DOI: 10.1089/neu.2010.1481. View

Faul M, Coronado V . Epidemiology of traumatic brain injury. Handb Clin Neurol. 2015; 127:3-13. DOI: 10.1016/B978-0-444-52892-6.00001-5. View

Liu L, Sun T, Liu Z, Chen X, Zhao L, Qu G . Traumatic brain injury dysregulates microRNAs to modulate cell signaling in rat hippocampus. PLoS One. 2014; 9(8):e103948. PMC: 4121204. DOI: 10.1371/journal.pone.0103948. View

Rockhill C, Jaffe K, Zhou C, Fan M, Katon W, Fann J . Health care costs associated with traumatic brain injury and psychiatric illness in adults. J Neurotrauma. 2011; 29(6):1038-46. DOI: 10.1089/neu.2010.1562. View

Blondal T, Jensby Nielsen S, Baker A, Andreasen D, Mouritzen P, Teilum M . Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods. 2012; 59(1):S1-6. DOI: 10.1016/j.ymeth.2012.09.015. View

Wang W, Visavadiya N, Pandya J, Nelson P, Sullivan P, Springer J . Mitochondria-associated microRNAs in rat hippocampus following traumatic brain injury. Exp Neurol. 2015; 265:84-93. PMC: 4346439. DOI: 10.1016/j.expneurol.2014.12.018. View

Papa L, Silvestri S, Brophy G, Giordano P, Falk J, Braga C . GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions. J Neurotrauma. 2014; 31(22):1815-22. PMC: 4224051. DOI: 10.1089/neu.2013.3245. View

Diaz-Arrastia R, Wang K, Papa L, Sorani M, Yue J, Puccio A . Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotrauma. 2013; 31(1):19-25. PMC: 3880090. DOI: 10.1089/neu.2013.3040. View

10.

Balakathiresan N, Chandran R, Bhomia M, Jia M, Li H, Maheshwari R . Serum and amygdala microRNA signatures of posttraumatic stress: fear correlation and biomarker potential. J Psychiatr Res. 2014; 57:65-73. DOI: 10.1016/j.jpsychires.2014.05.020. View

11.

Rao V, McCann U, Bergey A, Han D, Brandt J, Schretlen D . Correlates of apathy during the first year after traumatic brain injury. Psychosomatics. 2013; 54(4):403-4. DOI: 10.1016/j.psym.2013.01.001. View

12.

Jin X, Wu N, Wang L, Li J . Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases. Cell Mol Neurobiol. 2013; 33(5):601-13. PMC: 11497935. DOI: 10.1007/s10571-013-9940-9. View

13.

Papa L, Lewis L, Falk J, Zhang Z, Silvestri S, Giordano P . Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. Ann Emerg Med. 2011; 59(6):471-83. PMC: 3830977. DOI: 10.1016/j.annemergmed.2011.08.021. View

14.

Burda J, Bernstein A, Sofroniew M . Astrocyte roles in traumatic brain injury. Exp Neurol. 2015; 275 Pt 3:305-315. PMC: 4586307. DOI: 10.1016/j.expneurol.2015.03.020. View

15.

Nam J, Rissland O, Koppstein D, Abreu-Goodger C, Jan C, Agarwal V . Global analyses of the effect of different cellular contexts on microRNA targeting. Mol Cell. 2014; 53(6):1031-1043. PMC: 4062300. DOI: 10.1016/j.molcel.2014.02.013. View

16.

Mercier E, Boutin A, Lauzier F, Fergusson D, Simard J, Zarychanski R . Predictive value of S-100β protein for prognosis in patients with moderate and severe traumatic brain injury: systematic review and meta-analysis. BMJ. 2013; 346:f1757. DOI: 10.1136/bmj.f1757. View

17.

Powers C, Dickerson R, Zhang S, Rink C, Roy S, Sen C . Human cerebrospinal fluid microRNA: temporal changes following subarachnoid hemorrhage. Physiol Genomics. 2016; 48(5):361-6. PMC: 4855212. DOI: 10.1152/physiolgenomics.00052.2015. View

18.

Siddeek B, Inoubli L, Lakhdari N, Rachel P, Fussell K, Schneider S . MicroRNAs as potential biomarkers in diseases and toxicology. Mutat Res Genet Toxicol Environ Mutagen. 2014; 764-765:46-57. DOI: 10.1016/j.mrgentox.2014.01.010. View

19.

Meissner L, Gallozzi M, Balbi M, Schwarzmaier S, Tiedt S, Terpolilli N . Temporal Profile of MicroRNA Expression in Contused Cortex after Traumatic Brain Injury in Mice. J Neurotrauma. 2015; 33(8):713-20. DOI: 10.1089/neu.2015.4077. View

20.

McMahon P, Panczykowski D, Yue J, Puccio A, Inoue T, Sorani M . Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging. J Neurotrauma. 2014; 32(8):527-33. PMC: 4394160. DOI: 10.1089/neu.2014.3635. View